IMMUNOHUB Trademark
Trademark Overview
On Thursday, December 19, 2024, a trademark application was filed for IMMUNOHUB with the United States Patent and Trademark Office. The USPTO has given the IMMUNOHUB trademark a serial number of 98913188. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 19, 2024. This trademark is owned by Mea mente LLC. The IMMUNOHUB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Platform that provides information on immunotherapies such as bispecific T cell engagers and chimeric antigen receptors used to treat patients.
General Information
Serial Number | 98913188 |
Word Mark | IMMUNOHUB |
Filing Date | Thursday, December 19, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Thursday, December 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Platform that provides information on immunotherapies such as bispecific T cell engagers and chimeric antigen receptors used to treat patients. |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, December 19, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Friday, November 15, 2024 |
First Use In Commerce Date | Friday, November 15, 2024 |
Trademark Owner History
Party Name | Mea mente LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | New York, NY 10024 |
Trademark Events
Event Date | Event Description |
Thursday, December 19, 2024 | NEW APPLICATION ENTERED |